1. Ohyama, Y., Noshiro, M., Eggersten, G., Gotoh, O., Kato, Y., Bjorkhem, I., and Okuda, K. (1993). Structural characterization of the gene encoding rat 25-hydroxyvitamin D3 24-hydroxylase. Biochemistry 32, 76-82.

2. Akeno, N., Saikatsu, S., Kawane, T., and Horiuchi, N. (1997). Mouse vitamin D-24 hydroxylase molecular cloning, tissue distribution, a transcriptional regulation by 1(, 25-hydroxyvitamin D3. Endocrinology 138, 2233-2240.

3. Fu, G.K., Portale, A.A., and Miller, W.L. (1997). Complete structure of the human gene for the vitamin D 1(-hydroxylase. Cell. Biol. 16, 1499-1507.

4. Monkawa, T., Yoshida, T., Wakino, S., Shinki, T., Anazawa, H., DeLuca, H.F., Suda, T., Hayashi, M., and Sarut3:53 PM 1/3/03a, T. (1997). Molecular cloning of cDNA and genomic DNA for human 25-hydroxyvitamin D3 1(-hydroxylase. Biochem. Biophys. Res. Commun. 239, 527-533.

5. Shinki, T., Shimada, H., Wakino, S., Anazawa, H., Hayashi, M., Saruta, T., DeLuca, H.F., and Suda, T. (1997). Cloning and expression of rat 25-hydroxyvitamin D3- 1(-hydroxylase cDNA. Proc. Natl. Acad. Sci. (USA) 94,12920-12925.

6. Takeyama, K., Kitanaka S., Sato, T., Kobori, M. Yanagisawa, J., and Kato, S. (1997).

25-hydroxyvitamin D3 1(-hydroxylase and vitamin D synthesis. Science 277, 1827-1830.

7. Jehan, F., Ismail, R., Hanson, K., and DeLuca, H.F. (1998). Cloning and expression of the chicken 25-hydroxyvitamin D3 24-hydroxylase cDNA. Biochem. Biophys. Acta. 1395, 259-265.

8. Jones, G., Ramshaw, H. Zhang, A., Cook, R., Byford, V., White, J., and Petkovich, M. (1999). Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1( and CYP 24) in human nonsmall cell lung carcinomas. Endocrinology 140, 3303-3310.

9. Murayama, A., Takeyama, K., Kitanaka, S., Kodera, Y., Kawaguchi, Y., Hosoya, T., and Kato, S. (1999). Positive and negative regulations of the renal 25-hydroxyvitamin D3 1(-hydroxylase gene by the parathyroid hormone, calcitonin and 1(, 25(OH)2D3 in intact animals. Endocrinology 140, 2224-2231.

10. Evans, R. M. (1988). The steroid and thyroid hormone receptor superfamily. Science 240, 889-895.

11. Baker, A. R., McDonnel, D. P., Huges, M., Crisp, T. M., Mangelsdorf, D. J., Haussler, M. R., Pike, J. W., Shine, J., and O'Malley, B. W. (1988). Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc. Natl. Acad. Sci. (USA) 85, 3294-3298.

12. Burmester, J. K., Maeda, N., and DeLuca, H. F. (1988). Isolation and expression of rat 1,25-dihydroxyvitamin D3 receptor DNA. Proc. Natl. Acad. Sci. (USA) 85, 1005-1009.

13. Ozur, K., Sone, T., and Pike, J. W. (1991). The genomic mechanism of action of 1,25-dihydroxyvitamin D3. J. Bone Miner. Res. 6, 1021-1027.

14. DeLuca, H. F. (1984). The metabolism, physiology and function of vitamin D.

In: "Vitamin D: Basic and Clinical Aspects'' (R. Kumar, ed.), pp. 1. Martinus Nijhoff, Boston.

15. Mayer, E., Kadowabi, S., Williams, G., and Norman, A. W., (1984). Mode of action of 1,25-dihydroxyvitamin D. In: "Vitamin D: Basic and Clinical Aspects'' (R. Kumar, ed.), pp. 259. Martinus Nijhoff, Boston.

16. Reichel, H., Koeffler, P., and Norman, A. W. (1989). The role of the vitamin D endocrine system in health and disease. N. Engl. J. Med. 320, 980-991.

17. Owen, T. A., Aronow, M. S., Barone, L. M., Bettencourt, B., Stein G. S., and Lian, J. B. (1991). Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of bone cell phenotype: Dependency upon basal levels of gene expression, duration of exposure and bone matrix competency in normal rat osteoblast culture. Endocrinology 129, 3139-3146.

19. Pettifor, J. M., Ross, F. P. Travers, R., Glorieux, F. H., and DeLuca, H. F. (1981). Dietary calcium deficiency: A syndrome associated with bone deformities and elevated serum 1,25-dihydroxyvitamin D concentrations. Metab. Bone Dis. Relat. Res. 2, 301-305.

20. Teitelbaum, S. L., and Bollough, P. G. (1979). The pathophysiology of bone and disease. Am. J. Pathol. 96, 283.

21. Parfitt, A. M. (1983). The physiologic and clinical significance of bone histomorphometric data. In: "Bone Histomorphometric Data'' (R. Recker, ed.), pp. 143. CRC Press, Boca Raton, FL.

22. Parfitt, A.M., Drezner, M.K., Glorieux, F.H., Kanis, J.A., Malluche, H., Meunier, P.J., Ott, S.M., and Recker, R.R. (1987). Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR histomorphometry nomenclature committee. J. Bone Miner. Res. 2, 595-610.

23. Cole, D. E. C., Carpenter, T. O., and Gundberg, C. M. (1985). Serum osteocalcin concentrations in children with metabolic bone disease. J. Pediatr. 106, 770-776.

24. Gill, R.K.., Ramadan, D., Chesnut, C.H., IV, Lee, M.H., Patel, S.B., and Bell, N.H. (2000) Vitamin D-25-hydroxylase deficiency does not map to the CYP27 or CYP2D6 gene loci. J. Bone Miner. Res. 15, S1-S329.

25. Holick, M.F. (1994). McCollum award lecture 1994. Vitamin D: new horizons for the 21st century. Am. J. Clin. Nutr. 60, 619-630.

26. Holick, M.F. (1995). Environmental factors that influence the cutaneous production of vitamin D. Am. J. Clin. Nutr. 61 (suppl 3), 638S-645S.

27. Lips, P. (2001). Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr. Rev. 22, 477-501.

28. Krall, E.A., Sahyoun, N., Tannenbaum, S., Dallal, G.E., and Dawson-Hughes, B. (1989). Effect of vitamin D intake on seasonal variations in parathyroid secretion in postmenopausal women. N. Engl. J. Med. 321, 1777-1783.

29. Chapuy, M.C., Preziosi, P., Maamer, M., Arnaud S., Galan, P., Hercberg, S., and Meunier, P.J. (1997). Prevalnce of vitamin D insufficiency in an adult normal population. Osteoporos. Int. 7, 439-443.

30. Thomas, M.K., Lloyd-Jones, D.M., Thadhani, R.I., Shaw, A.C., Deraska, D.J., Kitch, B.T., Vamvakas, E.C., Dick, I.M., Prince, R.L., and Finkelstein, J.S. (1998). Hypovitaminosis D in medical inpatients. N. Engl. J. Med 338, 777-783.

31. Malabana, A.O., Veronikis, I.E., and Holick, M.F. (1998). Redefining vitamin D insufficiency. Lancet 351, 805-806.

32. Lips, P., Duong, T., Oleksik, A., Black D., Cummings, S., Cox, D., and Nickelsen, T. (2001). A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the Multiple Outcomes of Raloxifene Evaluation Clinical Trial. J. Clin. Endocrinol. Metab. 86, 1212-1221.

33. Khaw, K.T., Sneyd, M.J., and Compston, J. (1992). Bone density, parathyroid hormone and 25-hydroxyvitamin D concentrations in middle-aged women. Br. Med. J. 305, 273-277.

34. Ooms, M.E., Lips, P., Roos, J.C., van der Vijgh, W.J.F., Popp-Snijders, C., Bezemer, P.D., and Bouter, L.M. (1995). Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women. J. Bone Miner. Res. 10, 1177-1184.

35. Mezquita-Raya, P., Munoz-Torres, M., De Dios Luna, J., Luna, V., Lopez-Rodriguez, F., Torres-Vela, E., and Escobar-Jimenez, F. (2001). Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women. J. Bone Miner. Res. 16, 1408-1415.

36. Collins, D., Jasani, C., Fogelman, I., and Swaminathan, R. (1998). Vitamin D and bone minimal density. Osteoporos Int. 8, 110-114.

37. Delmas, P.D., and Meunier, P.J. (1992). Vitamin D3 and calcium to prevent hip fractures in elderly women. N. Engl. J. Med. 327, 1637-1642.

38. Holick, M.F. (1998). Vitamin D requirements for humans of all ages: new increased requirements for women and men 50 years and older. Osteoporos. Int. 8 (suppl 2), S24-S29.

39. Davies, M., Mawer, E.B., Hann, J.T., Stephens, W.P., and Tayler J.L. (1985). Vitamin D prophylaxis in the elderly: a simple, effective method suitable for large populations. Age Ageing 14, 349-354.

40. Weisman, Y., Schen, R.J., Eisenberg, Z., Amarilio, N., Graff, E., Edelstein-Singer, M., Goldray, D., and Harell, A. (1986). Single oral high-dose vitamin D3 prophylaxis in the elderly. J. Am. Geriatr. Soc. 34, 515-518.

41. Khaw, K.T., Scragg, R.,and Murphy S. (1994). Single-dose cholecalciferol suppresses the winter increases in parathyroid hormone concentrations in healthy older men and women. Am. J. Clin. Nutr. 59, 1040-1044.

42. Heikinheimo R.J., Inkovaara, J.A., Harju, E.J., Haavisto, M.V., Kaarela, R.H., Kataja, J.M., Kokko, A.M.L., Kolho, L.A., and Rajala, S.A. (1992). Annual injection of vitamin D and fractures of aged bones. Calci. Tissue Int. 51, 105-110.

42a. Prader, A., Illig, R., and Heierli, E. (1961). Eline besondere From der primaren/vitamin D-resistenten Rachitis mit Hypocalcemie un autosomal-dominanten Erbgang: Die hereditare Pseudo-Mangelrachi tis. Hely. Paediatr. Acta 16, 452-468.

43. Fraser, D., Kooh, S. W., Kind, P., Tanaka, Y., and DeLuca, H. F. (1973). Pathogenesis of hereditary vitamin D-dependent rickets: An inborn error of metabolism involving defective conversion of 25-hydroxyvitamin D to 1(,25-dihydroxy-vitamin D. N. Engl. J. Med. 289, 817-822.

44. Delvin, E. E., Glorieux, F. H., Marie, P. J., and Pettifor, J. M. (1981). Vitamin D dependency: Replacement therapy with calcitriol. J. Pediatr. 99, 26-34.

45. Labuda, M., Morgan, K., and Glorieux, F. H. (1990). Mapping autosomal recessive vitamin D-dependency Type I to chromosome 12q14 by linkage analysis. Am. J. Hum. Genet. 46, 28-36.

46. De Braekeleer, M., and Larochell, J. (1991). Population genetics of vitamin

D - dependent rickets in Northeastern Quebec. Ann. Hum. Genet. 55, 283-290.

47. Fu, G.K., Lin, D. Zhang, M.Y., Bikle, D.D., Shackleton, C.H., Miller, W.L., and Portale, A.A. (1997b). Cloning of human 25-hydroxyvitamin D1(-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Endocrinology 11, 1961-1970.

48. St. Arnaud, R., Messerlian, S., Moir, J.M., Omdahl, J.L., and Glorieux, F.H. (1997). The 25-hydroxyvitamin D3- 1(-hydroxylase gene maps to the pseudovitamin D deficiency rickets (PDDR) disease locus. J. Bone. Miner. Res. 12,1552-1559.

49. Wang, J.T., Lin, C.J., Burridge, S.M., Fu, G.K., Labuda, M., Portale, A.A., and Miller, W.L. (1998). Genetics of vitamin D 1(-hydroxylase deficiency in 17 families. Am. J. Hum. Genet. 63, 1694-1702.

50. Yoshida, T., Monkawa, T., Tenehouse, H.S., Goodyear, P., Shinki, T., Suda, T., Wakino, S., Hayashi, M., and Saruta, T. (1998). Two novel 1(-hydroxylase in French-Canadians with vitamin D dependency rickets type II. Kidney Int. 54, 1437-1443 (comments).

51. Kitanaka, S., Takeyama, K., Murayama, A., Sato, T., Okumura, K., Nogami, M., Hasegawa, Y., Niimi, H., Yanagisawa, J., Tanaka, T., and Kato, S. (1998). Inactivating mutations in the 25-hydroxyvitamin D3 1(-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N. Eng. J Med. 338, 653-661 (comments).

51a. Kitanaka, S., Murayama, A., Sakaki, T., Inoue, K., Seino, Y., Fukumoto, S., Shima, M., Yukizane, S., Takayanagi, M., Niimi, H., Takeyama, K. and Kato, S. (1999). No enzyme activity of 25-hydroxyvitamin D3 1(-hydroxylase gene product in pseudovitamin D-deficiency rickets with mild clinical manifestation. J. Clin. Endocrinol. Metab. 84, 4111-4117.

52. Smith, S.J., Rucka, A.K., Berry, J.L., Davies, M., Mylchreest, S. Paterson, C.R., Heath, D.A., Tassabehji, M., Read, A.P., Mee, A.P., and Mawer, E.B. (1999). Novel mutations in the 1(-hydroxylase (P450c1) gene in three families with pseudovitamin D-deficiency rickets resulting in loss of functional enzyme activity in blood derived macrophages. J. Bone Miner. Res. 14,730-739.

53. Glorieux, F. H., Arabian, A., and Delvin, E. E. (1995). Pseudo-vitamin D deficiency: Absence of 25-hydroxyvitamin D 1(-hydroxylase activity in human placenta decidua cells. J. Clin. Endocrinol. Metab. 80, 2255-2258.

54. Weisman, Y., Harell, A., Edelstein, S., David, M., Spirer, Z., and Golander, A. (1979). 1(, 25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 in vitro synthesis by human decidua and placenta. Nature 281, 317-319.

55. Delvin, E. E., and Arabian, A. (1987). Kinetics and regulation of 25-hydroxy-cholecalciferol 1(-hydroxylase from cells isolated from human term decidua. Eur. J. Biochem. 163, 659-662.

56. Diaz, L., Sanchez, I., Avila, E., Halhali, A., Vilchis, F., and Larrea, F. (2000). Identification of a 25-hydroxyvitamin D3 1(-hydroxylase gene transcription product in cultures of human syncytiotrophoblast cells. J. Clin. Endocrinol. Metab. 85,2543-2549.

56a. Fox, J., Maunder, E. M. W., Ranall, V. A., and Care, A. D. (1985). Vitamin D dependent rickets type I in pigs. Clin. Sci. 69, 541-548.

56b. Harmeyer, J. V., Grabe, C., and Winkley, I. (1982). Pseudovitamin D deficiency rickets in pigs. An animal model for the study of familial vitamin D dependency. Exp. Biol. Med. 7, 117-125.

56c. Dardenne, O., Prudhomme, J.O., Arabian, A., Glorieux, F.H. and St-Arnaud, R. (2001). Targeted inactivation of the 25-hyroxyvitamin D3-1 (alpha)-hydroxylase gene (CYP27-B1) create an animal model of pseudovitamin D-deficiency rickets. Endocrinology 142, 3135-3141.

57. Brooks, M. H., Bell, N. H., Love, L., Stern, P. H., Ordei, E., and Queener, S. J. (1978). Vitamin D dependent rickets type II resistance of target organs to 1,25-dihydroxyvitamin D. N. Engl. J. Med. 293, 996-999.

58. Marx, S. J., Spiegel, A. M., Brown, E. M., Gardner, D. G., Downs,R. W., Jr., Attie, M., Hamstra, A. J., and DeLuca, H. F. (1978). A familial syndrome of decrease in sensitivity of 1,25-dihydroxyvitamin D. J. Clin. Endocrinol. Metab. 47, 1303-1310.

59. Rosen, J. F., Fleischman, A. R., Fineberg, L., Hamstra, A., and DeLuca, H. F. (1979). Rickets with alopecia: An inborn error of vitamin D metabolism. J. Pediatr. 94, 729-735.

60. Liberman, U. A., Samuel, R., Halabe, A., Kauli, R., Edelstein, S., Weisman, Y., Papapoulos, S. E., Clemens, T. L., Fraher, L. J., and O'Riordan, J. L. H. (1980). End-organ resistance to 1,25-dihydroxy cholecalciferol. Lancet 1, 504-506.

61. Fujita, T., Nomura, M., Okajima, S., and Suzuya, H. (1980). Adult-onset vitamin D-resistant osteomalacia with unresponsiveness to parathyroid hormone. J. Clin. Endocrinol. Metab. 50, 927- 931.

62. Sockalsosky, J. J., Westrom, R. A., DeLuca, H. F., and Brown, D. M. (1980). Vitamin

D-resistant rickets: End-organ unresponsiveness to 1,25(OH)2D3. J. Pediatr. 96, 701-703.

63. Tauchiya, Y., Matsuo, N., Cho, H., Kumagai, M., Yasaka, A., Suda, T., Orimo, H., and Shiraki, M. (1980). An unusual form of vitamin-D-dependent rickets in a child: Alopecia and marked end-organ hyposensitivity to biological active vitamin D. J. Clin. Endocrinol. Metab. 51, 685- 690.

64. Bear, S., Tieder, M., Kohelet, D., Liberman, U. A., Vine, E., Bar-Joseph, G., Gabizon, D., Borochowitz, Z. U., Varon, M., and Modai, D. (1981). Vitamin D resistant rickets with alopecia: A form of end-organ resistance to 1,25-dihydroxyvitamin D. Clin. Endocrinol.14, 395-402.

65. Eil, C., Liberman, U. A., Rosen, J. F., and Marx, S. J. (1981). A cellular defect in hereditary vitamin D-dependent rickets type II: Defective nuclear uptake of 1,25-dihydroxyvitamin D in cultured skin fibroblasts. N. Engl. J. Med. 304,1588-1591.

66. Feldman, D., Chen, T., Cone, C., Hirst, M., Shari, S., Benderli, A., and Hochberg, Z. (1982). Vitamin D resistant rickets with alopecia: Cultured skin fibroblasts exhibit defective cytoplasmic receptors and unresponsiveness to 1,25(OH)2D3.J. Clin. Endocrinol. Metab. 55, 1020-1025.

67. Balsan, A., Garabedian, M., Liberman, U. A., Eil, C., Bourdeau, A., Guillozo, H., Grimberg, R., DeDeunff, M. J., Lieberherr, M., Guimbaud, P., Broyer, M., and Marx, S. J. (1983) Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: Two different clinical courses with two different cellular defects. J. Clin. Endocrinol. Metab. 57, 824-830.

68. Clemens, T. L., Adams, J. C., Horiuchi, N., Gilchrist, B. A., Cho, H., Ysuchiya, Y., Matsuo, N., Suda, T., and Holick, M. J. (1983). Interaction of 1,25-dihydroxyvitamin D3 with keratinocytes and fibroblasts from skin of a subject with vitamin D-dependent rickets type II: A model for the study of action of 1,25-dihydroxyvitamin D3. J. Clin. Endocrinol. Metab. 56, 824-830.

69. Griffin, J. E., and Zerwekh, J. E. (1983). Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. J. Clin. Invest. 72, 1190- 1199.

70. Liberman, U. A., Eil, C., and Marx, S. J. (1983). Resistance to 1,25-dihydroxyvitamin D: Association with heterogeneous defects in cultured skin fibroblasts. J. Clin. Invest. 71, 192-200.

71. Malloy, P.J., Weisman, Y., Feldman D. (1994). Hereditary 1 alpha,25-dihydroxyviamin D-resistant rickets resulting from a mutation in the vitamin D receptor deoxyribonucleic acid-binding domain. J. Clin. Endocrinol. Metab. 78, 313-316.

72. Chen, T. L., Hirst, M. A., Cone, C. M., Hochberg, Z., Tietze, H. U., and Feldman, D. (1984). 1,25-Dihydroxyvitamin D resistance, rickets and alopecia: Analysis of receptors and bioresponse in cultured skin fibroblasts from patients and parents.

J. Clin. Endocrinol. Metab. 59, 383-388.

73. Hochberg, Z., Benderli, Z., Levy, J., Weisman, Y., Chen, T., and Feldman, D. (1984). 1,25-Dihydroxyvitamin D resistance, rickets and alopecia. Am. J. Med. 77, 805-811.

74. Marx, S. J., Liberman, U. A., Eil, C., Gamblin, G. T., DeGrange,D. A., and Balsan, S. (1984). Hereditary resistance to 1,25-dihydroxyvitamin D. Recent Prog. Horm. Res. 40, 589-620.

75. Hirst, M. A., Hochman, H. I., and Feldman, D. (1985). Vitamin D resistance and alopecia: A kindred with normal 1,25-dihydroxy-vitamin D3 binding but decreased receptor affinity for deoxyribonucleic acid. J. Clin. Endocrinol. Metab.60, 490-495.

76. Castells, S., Greig, F., Fusi, M. A., Finberg, L., Yasumura, S., Liberman, U. A., Eil, C., and Marx, S. J. (1986). Severely deficient binding of 1,25-dihydroxyvitamin D to its receptor in a patient responsive to high doses of this hormone. J. Clin. Endocrinol. Metab. 63, 252-256.

77. Fraher, L. J., Karmali, R., Hinde, F. R. J., Hendy, G. N., Jani, H., Nicholson, L., Grant, D., and O'Riordan, J. L. H. (1986). Vitamin D-dependent rickets type II: Extreme end organ resistance to 1,25-dihydroxyvitamin D3 in a patient without alopecia. Eur. J. Pediatr. 145, 389-395.

78. Takeda, E., Kuzoda, T., Saijo, T., Toshima, K., Naito, E., Kobashi, H., Iwakuni, Y., and Miyao, M. (1986). Rapid diagnosis of vitamin D-dependent rickets type II by use of phyto-hemagglutinin-stimulated lymphocytes. Clin. Chim. Acta 155, 245-250.

79. Takeda, E., Kuroda, Y., Saijo, T., Naito, E., Kobashi, H., Yokota, I., and Miyao, M. (1987). 1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia. Pediatrics 80, 97-101.

80. Takeda, E., Yokota, I., Kawakami, I., Hashimoto, T. T., Kuroda, Y., and Arase, S. (1989). Two siblings with vitamin D-dependent rickets type II: No recurrence of rickets for 14 years after cessation of therapy. Eur. J. Pediatr. 149, 54-57.

81. Saijo, T., Ito, M., Takeda, E., Mahbubul Huq, A. H. M., Naito, E., Yokota, I., Sine, T., Pike, J. W., and Kuroda, Y. (1991). A unique mutation in the vitamin D receptor gene in three Japanese patients with vitamin D-dependent rickets type II: Utility of single-strand conformation polymorphism analysis for heterozygous carrier detection. Am. J. Hum. Genet. 49, 668-673.

82. Simonin, G., Chabrol, B., Moulene, E., Bollini, G., Strouc, S., Mattei, J. F., and Giraud, F. (1992). Vitamin D resistant rickets type II: Apropos of 2 cases. Pediatric 47, 817-820.

83. Hewison, M., Rut, A. R., Kristjansson, K., Walker, R. E., Dillon,M. J., Hughes, M. R., and O'Riordan, J. L. H. (1993). Tissue resistance to 1,25-dihydroxyvitamin D without a mutation of the vitamin D receptor gene. Clin. Endocrinol. 39, 663-670.

84. Lin, J. P., and Uttley, W. E. (1993). Intraatrial calcium infusions, growth and development in end-organ resistance to vitamin D. Arch. Dis. Child. 69, 689-692.

85. Yagi, H., Ozono, K., Miyake, H., Nagashima, K., Kuroume, T., and Pike, J. W. (1993). A new point mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor in a kindred with hereditary 1,25-dihydroxyvitamin D resistant rickets. J. Clin. Endocrinol. Metab. 76, 509-512.

86. Whitfield, G.K., Selznick, S.H., Haussler, C.A., Hsieh, J.C., Galligan M.A., Jurutka, P.W., Thompson, P.D., Lee, S.M., Zerwekh, J.E., and Haussler, M.R.(1996). Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: Point mutations confer reduced transactivation in response to ligand and impaired intereaction with the retinoid X receptor heterodimeric partner. Mol. Endocrinol. 10, 1617-1631.

87. Lin Nu-T., Malloy, P.J., Sakati, N., Al-Ashwal, A., and Feldman, D. (1996). A novel mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor causes hereitary 1,25-dihydroxyvitamin D resistant rickets. J. Clin. Endocrinol. Metab. 81, 2564-2569.

88. Hawa, N.S. Cockerill, F.J., Vadher, S., Hewison, M., Rut, A.R., Pike, J.W., O'Riordan, J.L.H., and Farrow, S.M. (1996). Identification of a novel mutation in hereditary vitamin D resistant rickets causing exon skipping. Clin. Endocrinol. 45, 85-92.

89. Mechica, J.B., Leite, M.O.R., Mendoca, B.B., Frazzatto, E.S.T., Borelli, A., and Latronico, A.C. (1997). A novel nonsense mutation in the first zinc finger of the vitamin D receptor causing hereditary 1,25-dihydroxyvitamin D resistant rickets. J. Clin. Endocrinol Metab. 82, 3892-3894.

90. Malloy, P.J. Eccleshall, T.R., Gross, C., van Maldergem, L, Bouillion, R., and Feldman, D. (1997). Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness. J. Clin. Invest. 99, 297-304.

91. Cockerill, F.J., Hawa, N.S. Yousaf, N., Hewison, M., O'Riordan, J.F.L., and Farrow, S.M. (1997). Mutations in the vitamin D receptor gene in three kindreds associated with hereditary vitamin D resistant rickets. J. Clin. Endocrinol. Metab. 82,3156-3160.

92. Zhu, W.J., Malloy, P.J., Delvin, E., Chabot, G., Feldman, D. (1998). Hereditary 1,25-dihydroxyvitamin D-resistant rickets due to an opal mutation causing premature termination of the vitamin D receptor. J. Bone. Miner. Res. 13,259-264.

93. Malloy, P.J., Zhu, W., Zhao, X.Y., Pehling, G.B., Feldman, D. (2001). A novel inborn error in the ligand-binding domain of the vitamin D receptor causes hereditary vitamin D-resistant rickets. Mol. Genet. Metab. 73, 138-148.

94. Nguyen, T.M., Adiceam, P., Kottler, M.L., Guillozo, M., Rizk-Rabin, F., Brouillard, F., Lagier, P., Palix, C., Garnier, J.M., and Garabedian, M. (2002). Tryptophan missense mutation in the ligand-binding domain of the vitamin D receptor causes severe resistance to 1,25-dihyroxyvitamin D. J. Bone Miner. Res. 17, 1728-1737.

94a. Malloy, P.J., Pike, J.W., and Feldman, D. (1999). The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr. Rev. 20, 156-188.

95. Malloy, P.J., Xu, R., Peng., L., Clark, P.A., and Feldman D. (2002). A novel mutation in helix 12 of the VDR impairs coactivator interaction and causes hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia. J. Bone Miner. Res. 2002 Program & abstract, S216.

95a. Malloy P.J., Zhu W., Bouillon R., Feldman D. (2002). A novel non-sense mutation in the ligand binding domain of the vitamin D receptor causes hereditary 1,25-dihydroxyvitamin D-resistant rickets Mol. Genet. Metab. 77:314-318.

95b. Malloy P.J., Xu R, Peng I., Peleg S., Al-Ashwal A., Feldman D. (2004). Hereditary 1,25-dihydroxyvitamin D-resistant rickets due to a mutation causing multiple defects in vitamin D receptor function. Endocrinology 145, 5106-5114.

95c. Nguyen M., d’Alesio A., Pascussi J.M., Kumar R., Griffin M.D., Dong X., Guillozo H., Rizk-Rabin M., Sinding C., Bounéres P., Jehan F., Garabédian M. (2006). Vitamin D resistant rickets and type 1 diabetes in a child with compound heterozygous mutations of the vitamin D receptor (L263R and R3915): dissociated responses of the CYP-24 and rel-B promotors to 1,25-dihydroxyvitamin D3. J. Bone Miner. Res. 21:886-894.

96. Marx, S. J., Bliziotes, M. M., and Nanes, M. (1986). Analysis of the relation between alopecia and resistance to 1,25-dihydroxyvitamin D. Clin. Endocrinol. 25, 373-381.

97. Strumpf, W. E., Sar, M., and Reid, F. A. (1979). Target cells for 1,25-dihydroxyvitamin D in intestinal tract, stomach, kidney, skin, pituitary and parathyroid. Science 206, 188-190.

98. Li, Y.C., Piroo, A.E., Amling, M., Delling, G., Baron, R., Bronson, R., and Demay, M.B. (1997). Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. (USA) 94, 9831-9835.

99. Yoshizawa T., Handa, Y., Uematsu, Y., Takeda, S., Sekine, K., Yoshihara, Y., Kawakami, T., Arioka, K., Sato, H., Uchiyama, Y., Masushige, S., Fukamizu, A., Matsumoto, T., and Kato, S. (1997). Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat. Genetics 16, 391-396.

100. Delling, G., Demay, M.B. (1998). Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 139, 4391-4396.

101. Malloy, P. J., Hochberg, Z., Pike, J. W., and Feldman, D. (1989). Abnormal binding of vitamin D receptors to deoxyribonucleic acid in a kindred with vitamin D dependent rickets type II. J. Clin. Endocrinol. Metab. 68, 263-269.

102. Malloy, P. J., Hochberg, Z., Tiosano, D., Pike, J. W., Hughes, M. R., and Feldman, D. (1990). The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families. J. Clin. Invest. 86, 2017-2079.

103. Ritchie, H. H., Hughes, M. R., Thompson, E. T., Hochberg, Z., Feldman, D., Pike, J. W., and O'Mally, B. W. (1989). An ochre mutation in the vitamin D receptor gene causes hereditary 1,25-dihydroxyvitamin D3 resistant rickets in three families. Proc. Natl. Acad. Sci. (USA) 86, 9783-9787.

104. Takeda, E., Yokota, I., Ito, M., Kobashi, I., Saijo, T., and Kuroda, Y. (1990). 25-hydroxyvitamin D-24-hydroxylase in phyto-hemagglutinin-stimulated lymphocytes: Intermediate bioresponse to 1,25-dihydroxyvitamin D3 of cells from parents of patients with vitamin D dependent rickets type II. J. Clin. Endocrinol. Metab. 70, 1068 -1074.

105. Koren, R., Ravid, A., Liberman, U. A., Hochberg, Z., Weisman, J., and Novogrodsky, A. (1985). Defective binding and functions of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin D. J. Clin. Invest. 76, 2012-2015.

106. Liberman, U. A., Eil, C., and Marx, S. J. (1986). Receptor positive hereditary resistance to 1,25-dihydroxyvitamin D. Chromatography of hormone-receptor complexes on DNA-cellulose shows two classes of mutations. J. Clin. Endocrinol. Metab. 62, 122-126.

107. Hughes, M. R., Malloy, P. J., Kieback, D. G., Kesterson, R. A., Pike, J. W., Feldman, D., and O'Malley, B. W. (1988). Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science 242, 1702-1705.

108. Sone, T., Marx, S. J., Liberman, U. A., Pike, J. W. (1990). A unique point mutation in the human vitamin D receptor chromosomal gene confers hereditary resistance to 1,25-dihydroxyvitamin D3. Mol. Endocrinol. 4, 623-631.

109. Barsony, J., Pike, J. W., DeLuca, H. F., and Marx, S. J. (1990). Immunocytology with microwave-fixed fibroblasts shows 1 alpha, 24-dihydroxyvitamin D3-dependent rapid and estrogen-dependent slow reorganization of vitamin D receptors. J. Cell Biol. 111, 2385-2395.

110. Sone, T., Scott, R. A., Hughes, M. R., Malloy, P. J., Feldman, D., O'Malley, B. W., Pike, J. W. (1989). Mutant vitamin D receptors which confer hereditary resistance to 1,25-dihydroxyvitamin D3 in human are transcriptionally inactive in vitro. J. Biol. Chem. 264, 20230-20234.

110a. Liberman, U. A., Eil, C., Holst, P., Rosen, J. F., and Marx, J. S. (1983). Hereditary resistance to 1,25-dihydroxyvitamin D: defective function of receptors for 1,25-dihydroxyvitamin D in cells cultured from bone. J. Clin. Endocrinol. Metab. 57, 958-962.

111. Kristjansson, K., Rut, A. R., Hewison, M., O'Riordan, J. L. H., and Hughes, M. R. (1993). Two mutations in the hormone binding domain of the vitamin D receptor causes tissue resistance to 1,25-dihydroxyvitamin D3. J. Clin. Invest. 92,12-16.

/ 112. Weise, R. J., Goto, H., Prahl, J. M., Marx, S. J., Thomas, M., Al-Aqeel, A., and DeLuca, H. F. (1993). Vitamin D-dependency rickets type II: Truncated vitamin D receptor in three kindreds. Mol. Cell Endocrinol. 90, 197-201.

113. Rochel N., Wurtz, J.M., Mitschler, A., Klaholz, B., Moras, D. (2000). The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol. Cell 5, 173-179.

114. Rut, A. R., Hewison, K., Kristjansson, K., Luisi, B., Hughes, M., and O'Riordan, J. L. H. (1994). Two mutations causing vitamin D resistant rickets: Modelling on the basis of steroid hormone receptor DNA-binding domain crystal structures. Clin. Endocrinol. 41, 581-590.

115. Barsony, J., McKoy, W., DeGrange, D. A., Liberman, U. A., and Marx S. J. (1989). Selective expression of a normal action of 1,25-dihydroxyvitamin D3 receptor in human skin fibroblasts with hereditary severe defects in multiple action of this receptor. J. Clin. Invest. 83, 2093-2101.

116. Freedman, L.P. (1999). Increasing the complexity of coactivation in nuclear receptor signaling. Cell 97, 5-8.

117. Gamblin, G. T., Liberman, U. A., Eil, C., Downs, R. W., Jr., DeGrange, D. A., and Marx, S. J. (1985). Vitamin D-dependent rickets type II, defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts.J. Clin. Invest. 75, 954-960.

118. Balsan, S., Garabedian, M., Larchet, M., Gorski, A. M., Cournot, G., Tau, C., Bourdeau, A., Silve, C., and Ricour, C. (1986). Long term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. J. Clin. Invest. 77, 1661-1667.

119. Barsony, J., and Marx, S. J. (1988). A receptor-mediated rapid action of 1(, 25-dihydroxycholecalciferol: Increase of intracellular cyclic GMP in human skin fibroblasts. Proc. Natl. Acad. Sci. (USA) 85, 1223-1226.

120. Bliziotes, M., Yergey, A. L., Nanes, M. S., Muenzer, J., Begley, M. G., Vieira, N. E., Kher, K. K., Brandi, M. L., and Marx, S. J. (1988). Absent intestinal response to calciferols in hereditary resistance to 1,25-dihydroxyvitamin D: Documentation and effective therapy with high dose intravenous calcium infusions. J. Clin. Endocrinol. Metab. 66, 294-300.

121. Weisman, Y., Bab, I., Gazit, D., Spirer, Z., Jaffe, M., and Hochberg, Z. (1987). Long-term intracaval calcium infusion therapy in end-organ resistance to 1,25-dihydroxyvitamin D. Am. J. Med. 83, 984-990.

122. Sakati, N., Woodhouse, N. T. Y., Niles, N., Harji, H., DeGrange, D. A., and Marx, S. J. (1986). Hereditary resistance to 1,25-dihydroxyvitamin D: Clinical and radiological improvement during high-dose oral calcium therapy. Hormone Res. 24, 280-287.

123. Adams, J. S., and Gacad, M. A. (1988). Phenotypic diversity of the cellular 1,25-dihydroxyvitamin D3-receptor interaction among different generations of new world primates. J. Clin. Endocrinol. Metab. 666, 224-229.

124. Liberman, U. A., DeGrange, D., and Marx, S. J. (1985). Low affinity of the receptor for 1 alpha, 25-dihydroxyvitamin D3 in the marmoset, a New World monkey. FEBS Lett. 182, 385-389.

125. Shinki, T., Shiina, Y., Takanshi, N., Tamoika, Y., Koizumi, H., and Suda, T. (1983). Extremely high circulating levels of 1,25-dihydroxyvitamin D3 in the marmoset, a New World monkey. Biochem. Biophys. Res. Commun. 114, 452-457.

126. Takahashi, N., Suda, S., Shinki, T., Horiuchi, N., Shina, Y., Tanioka, Y., Koizumi, H., and Suda, T. (1985). The mechanisms of end-organ resistance to 1 alpha, 25-dihydroxycholecalciferol in the common marmoset. Biochem. J. 227, 555-563.

127. Gacad, M. A., and Adams, J. S. (1993). Identification of competitive binding component in vitamin D resistant new world primate cells with a low affinity but high capacity for 1,25-dihydroxyvitamin D3.J. Bone Miner. Res. 8, 27-35.

128. Arbelle, J.E., Chen, H., Gacad, M.A., Allegretto, E.A. Pike, J.W., and Adams, J.S. (1996). Inhibition of vitamin D receptor-retinoid X receptor-vitamin D response element complex formation by nuclear extracts of vitamin D-resistant New World primate cells. Endocrinology 137, 786-789.

129. Lipsett, M. B., Chrousos, G. P., Tomita, M., Brandon, D. D., and Loriaux, D. L. (1985). The defective glucocorticoid receptor in man and non-human primates. Recent Prog. Horm. Res. 41, 199-241.

130. Chen, C.H., Sakai, Y., and Demay, M.B. (2001). Targeting expression of the human vitamin D receptor to the keratinocytes of vitamin D receptor null mice prevents alopecia. Endocrinology 142, 5386.